David R. Boulware

21.3k total citations · 2 hit papers
294 papers, 10.3k citations indexed

About

David R. Boulware is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, David R. Boulware has authored 294 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Epidemiology, 199 papers in Infectious Diseases and 42 papers in Surgery. Recurrent topics in David R. Boulware's work include Fungal Infections and Studies (164 papers), Antifungal resistance and susceptibility (141 papers) and Nail Diseases and Treatments (54 papers). David R. Boulware is often cited by papers focused on Fungal Infections and Studies (164 papers), Antifungal resistance and susceptibility (141 papers) and Nail Diseases and Treatments (54 papers). David R. Boulware collaborates with scholars based in United States, Uganda and United Kingdom. David R. Boulware's co-authors include David B. Meya, Radha Rajasingham, Joshua Rhein, Paul R. Bohjanen, Tom Chiller, Nelesh P. Govender, David W. Denning, Angela Loyse, Benjamin J. Park and Nathan C. Bahr and has published in prestigious journals such as New England Journal of Medicine, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

David R. Boulware

279 papers receiving 10.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

2017 1.3k citations Radha Rajasingham, Joseph N Jarvis et al. profile →
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis

2022 298 citations Radha Rajasingham, Nelesh P. Govender et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David R. Boulware	6.9k	6.8k	1.1k	1.0k	731	294	10.3k
Li‐Min Huang	6.4k 0.9×	4.0k 0.6×	1.6k 1.4×	2.2k 2.2×	718 1.0×	566	13.4k
Peter F. Wright	13.2k 1.9×	7.5k 1.1×	1.1k 0.9×	1.3k 1.3×	686 0.9×	339	19.0k
Alexander L. Greninger	2.7k 0.4×	6.1k 0.9×	326 0.3×	2.1k 2.0×	536 0.7×	277	10.6k
Jeannette Guarner	3.1k 0.4×	3.5k 0.5×	1.7k 1.5×	1.2k 1.2×	1.2k 1.6×	206	8.9k
Barbara D. Alexander	7.0k 1.0×	6.4k 0.9×	656 0.6×	681 0.7×	282 0.4×	176	10.0k
Angela M. Caliendo	5.4k 0.8×	4.8k 0.7×	426 0.4×	810 0.8×	539 0.7×	185	10.6k
Gregory A. Poland	7.7k 1.1×	4.7k 0.7×	646 0.6×	3.7k 3.6×	1.0k 1.4×	411	16.2k
Steffen Stenger	3.0k 0.4×	3.4k 0.5×	783 0.7×	1.7k 1.7×	760 1.0×	126	9.1k
Massimo Clementi	3.7k 0.5×	2.8k 0.4×	1.1k 1.0×	1.8k 1.8×	618 0.8×	325	9.8k
Paul Griffiths	11.5k 1.7×	3.7k 0.5×	745 0.7×	802 0.8×	688 0.9×	297	14.9k

Countries citing papers authored by David R. Boulware

Since Specialization

Citations

This map shows the geographic impact of David R. Boulware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Boulware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Boulware more than expected).

Fields of papers citing papers by David R. Boulware

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Boulware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Boulware. The network helps show where David R. Boulware may publish in the future.

Co-authorship network of co-authors of David R. Boulware

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Boulware. A scholar is included among the top collaborators of David R. Boulware based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Boulware. David R. Boulware is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Fan, James Fisher, David B. Meya, et al.. (2024). Postmortem Analysis of Dolutegravir, Tenofovir, Lamivudine, and Efavirenz Penetration in Multiple Central Nervous System Compartments. The Journal of Infectious Diseases. 230(5). 1215–1223. 2 indexed citations

Okafor, Elizabeth C, Liliane Mukaremera, Kathy Huppler Hullsiek, et al.. (2024). Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis. The Journal of Infectious Diseases. 231(2). 521–531. 1 indexed citations

Bahr, Nathan C., Susan E. Beekmann, Philip M. Polgreen, et al.. (2024). Infectious Diseases Physician Management of Cryptococcal Meningitis in North America—Is Single High-Dose Liposomal Amphotericin B Being Used?. Open Forum Infectious Diseases. 11(6). ofae120–ofae120. 4 indexed citations

Hartman, Katrina M, Via Rao, Aubrey A Hagen, et al.. (2024). A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment. Open Forum Infectious Diseases. 11(7). ofae224–ofae224.

Thorlund, Kristian, Davey M. Smith, Nicholas J. White, et al.. (2023). The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials. SHILAP Revista de lepidopterología. 3(1). 53–53. 5 indexed citations

Kagimu, Enock, Morris K Rutakingirwa, Kristoffer E. Leon, et al.. (2023). Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis. Current HIV/AIDS Reports. 20(6). 379–393. 2 indexed citations

Titanji, Boghuma K, David R. Boulware, & Rachel Bender Ignacio. (2023). Strategies for Expediting Clinical Trials in the Next Public Health Emergency. JAMA Health Forum. 4(9). e233191–e233191. 3 indexed citations

Ellis, Jayne, Ananta Bangdiwala, Caleb P Skipper, et al.. (2023). Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV. Open Forum Infectious Diseases. 10(9). ofad449–ofad449. 3 indexed citations

Nalintya, Elizabeth, Richard Kwizera, Ann Fieberg, et al.. (2023). Prevalence of Histoplasma Antigenuria among Outpatient Cohort with Advanced HIV in Kampala, Uganda. Journal of Fungi. 9(7). 757–757. 4 indexed citations

10.

Pastick, Katelyn A, Enock Kagimu, Kenneth Ssebambulidde, et al.. (2022). Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic Review. Open Forum Infectious Diseases. 9(10). ofac513–ofac513. 4 indexed citations

11.

Bangdiwala, Ananta, Erika van Schalkwyk, Caleb P Skipper, et al.. (2022). Evaluation of the effectiveness of a South African laboratory cryptococcal antigen screening programme using a retrospective cohort and a cluster-randomised trial design. BMJ Open. 12(8). e054057–e054057. 2 indexed citations

12.

Facente, Shelley N., Angela M. Reiersen, Eric J. Lenze, David R. Boulware, & Jeffrey D. Klausner. (2021). Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Drugs. 81(18). 2081–2089. 26 indexed citations

13.

Abassi, Mahsa, Ananta Bangdiwala, Edwin Nuwagira, et al.. (2020). Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis. Clinical Infectious Diseases. 73(9). e3077–e3082. 16 indexed citations

14.

Boulware, David R., et al.. (2020). Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co‐infection. Mycoses. 63(8). 840–853. 22 indexed citations

15.

Gerstein, Aleeza C., Tami McDonald, Yina Wang, et al.. (2019). Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection. mBio. 10(4). 41 indexed citations

16.

Mukaremera, Liliane, Tami McDonald, Judith N. Nielsen, et al.. (2019). The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence. Infection and Immunity. 87(5). 41 indexed citations

17.

Mpoza, Edward, Liliane Mukaremera, Andrew Akampurira, et al.. (2018). Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection. PLoS ONE. 13(1). e0190652–e0190652. 22 indexed citations

18.

Bahr, Nathan C., Anil A. Panackal, Michelle Durkin, et al.. (2018). Cryptococcal meningitis is a cause for cross‐reactivity in cerebrospinal fluid assays for anti‐Histoplasma, anti‐Coccidioides and anti‐Blastomyces antibodies. Mycoses. 62(3). 268–273. 6 indexed citations

19.

Chen, Yuan, Dena L. Toffaletti, Jennifer L. Tenor, et al.. (2014). The Cryptococcus neoformans Transcriptome at the Site of Human Meningitis. mBio. 5(1). e01087–13. 84 indexed citations

20.

Wiesner, Darin L., Jennifer Corcoran, Tami McDonald, et al.. (2012). Cryptococcal Genotype Influences Immunologic Response and Human Clinical Outcome after Meningitis. mBio. 3(5). 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact